Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in inducible gene expression systems

F M Rossi1, H M Blau

  • 1Department of Molecular Pharmacology, Stanford University School of Medicine, CA, USA. frossi@leland.stanford.edu

Current Opinion in Biotechnology
|November 20, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of prostaglandin-degrading enzyme 15-PGDH rejuvenates aged muscle mass and strength.

Science (New York, N.Y.)·2020
Same author

From mini-puberty to pre-puberty: early impairment of the hypothalamus-pituitary-gonadal axis with normal testicular function in children with non-mosaic Klinefelter syndrome.

Journal of endocrinological investigation·2020
Same author

Epicardial fat: the role of testosterone and lipid metabolism in a cohort of patients with Klinefelter syndrome.

Metabolism: clinical and experimental·2019
Same author

NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways.

Leukemia·2017
Same author

Fluid intelligence, traits of personality and personality disorders in a cohort of adult KS patients with the classic 47, XXY karyotype.

Journal of endocrinological investigation·2017
Same author

NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components.

Leukemia·2017

Researchers have improved gene expression control systems for cells and animals. New tetracycline and rapamycin-based methods allow precise regulation of gene activity, enabling safer expression of toxic or therapeutic genes.

Area of Science:

  • Molecular Biology
  • Gene Regulation
  • Biotechnology

Background:

  • Controlling gene expression is crucial for various biological applications.
  • Previous tetracycline-responsive systems suffered from high background expression.
  • Original FK506-inducible systems had undesirable cytostatic side effects.

Purpose of the Study:

  • To present advancements in inducible gene expression systems.
  • To overcome limitations of existing tetracycline-responsive and FK506-inducible systems.
  • To enable precise control over the timing and level of gene expression.

Main Methods:

  • Development of tetracycline-sensitive transcriptional repressors to reduce background expression.
  • Isolation of novel rapamycin analogues for FK506-inducible system activation.

Related Experiment Videos

  • Testing of modified systems for controlled gene expression in cellular and animal models.

    • Main Results:

    • Successfully resolved high background expression issues in tetracycline-responsive promoters.
    • Identified rapamycin analogues that activate the FK506 system without cytostatic effects.
    • Demonstrated the feasibility of regulated expression for toxic genes, growth arrest genes, and therapeutic products.

    Conclusions:

    • Advanced tetracycline and rapamycin-based systems offer unprecedented control over gene expression.
    • These refined systems facilitate the safe and effective use of previously challenging gene expression strategies.
    • The improved systems have broad applications in research, biotechnology, and therapeutics.